Evaluation, in three provinces, of the introduction and impact of China's National Essential Medicines Scheme
about
The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling StudyThe impact of China's national essential medicine system on improving rational drug use in primary health care facilities: an empirical study in four provinces.How China's new health reform influences village doctors' income structure: evidence from a qualitative study in six counties in ChinaHealth system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal StudyEfficiency and productivity measurement of rural township hospitals in China: a bootstrapping data envelopment analysis.Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studiesDo changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countriesThe evolution of Reference Drug Lists and Clinical Practice Guidelines in the public health system of a middle-income countryEffects of the National Essential Medicine System in reducing drug prices: an empirical study in four Chinese provinces.Child health security in China: a survey of child health insurance coverage in diverse areas of the country.The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study.A cross-sectional analysis of prescription and stakeholder surveys following essential medicine reform in Guangdong Province, China.Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study.Urban-rural inequality regarding drug prescriptions in primary care facilities - a pre-post comparison of the National Essential Medicines Scheme of China.Assessing dose-response effects of national essential medicine policy in China: comparison of two methods for handling data with a stepped wedge-like design and hierarchical structure.Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform.The reform of the essential medicines system in China: a comprehensive approach to universal coverage.Hospital pharmacists' knowledge of and attitudes towards the implementation of the National Essential Medicines System: a questionnaire survey in western ChinaDual practice by doctors working in South and East Asia: a review of its origins, scope and impact, and the options for regulation.Country and regional variations in purchase prices for essential cancer medications.Impact of China's essential medicines scheme and zero-mark-up policy on antibiotic prescriptions in county hospitals: a mixed methods study.Effects of Public Hospital Reform on Inpatient Expenditures in Rural China.Perceived impacts of the national essential medicines system: a cross-sectional survey of health workers in urban community health services in China.The effect of essential medicines programme on rational use of medicines in China.Protecting patients with cardiovascular diseases from catastrophic health expenditure and impoverishment by health finance reform.The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China.Does providing more services increase the primary hospitals' revenue? An assessment of national essential medicine policy based on 2,675 counties in China.Effects of prescription restrictive interventions on antibiotic procurement in primary care settings: a controlled interrupted time series study in China.Medical expenses of urban Chinese patients with stomach cancer during 2002-2011: a hospital-based multicenter retrospective study.Study on essential drug use status and its influencing factors among cerebral infarction inpatients in county level hospitals of Anhui Province, China.Prevalence of hypertension and hypertension control rates among elderly adults during the cold season in rural Northeast China: a cross-sectional study.Making medicines more accessible in China: An empirical study investigating the early progress of essential medicine systemA survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitalsThe Effect of China's National Essential Medicine Policy on Health Expenses: Evidence From a National Study
P2860
Q28546995-596F988A-B657-41E8-9E87-377DF4C684F1Q30390323-5E5AD41F-CA04-491E-8CC4-4ED2624562E0Q30651311-ABB77364-CDDA-447B-9A7C-7293E791B8E8Q30726334-B712ED25-1F7A-4AE5-A7DB-12B65A3AD055Q31142001-DCEB1462-A43D-4CF8-B87E-B32545696B94Q33697280-ADFF2873-5F63-47A2-B6DA-807DBE93BD1CQ33699228-586C345F-E4CD-47B7-9A7C-DB942405EE25Q34065328-F5BB1A24-B160-4451-95F8-27A58B11999AQ34266928-4959807B-488F-4B3F-AD09-A12A64921606Q34272917-832AB81D-D5AC-41FD-A0E4-81366830670CQ34767907-15E3CE1C-A6F3-476D-8E4A-960EADFB4C65Q35194048-91C7BDA6-502F-4D4F-A760-78F91128392DQ35783822-975BEDB2-0181-40BC-B777-835BCEA9A19AQ35899399-D71DA0EF-9EE0-44BD-AEAA-2BC8FD3EF141Q36343553-1BF61CA0-5717-4C89-A735-A2FA78AD5E4CQ36714694-388E05A0-8E2C-4A8B-8CE3-39E798BBD49AQ36978076-AC0D5E4B-FCC0-423F-A8E2-1C02828FCB94Q37113238-CD3CF5F4-5EA1-49F0-A43B-0AC24358F91FQ38154812-58B85AEE-DA50-451A-ABD0-84C2F85DAFEEQ38610498-9ABD3533-402C-4BCE-B3ED-D722B1D1BD93Q39407023-99322B01-9976-4169-A06A-1F4C69E6002BQ40026683-264107A7-6A9A-4081-B19C-912722A13BACQ40485574-9B3CDA70-C457-4774-AB6F-3A995AB8A77AQ41139474-F100A97B-C274-497F-A13B-E88B896EBD4CQ41277598-90BFC949-40DA-4047-B0E5-529D7B1E49ADQ47110349-ABED2C20-9312-4A5D-B0F8-F8844CE6E1E9Q48235183-8703437C-9617-414F-91B2-0A8769E1DB5BQ49679204-478BE6F2-068A-4F89-B433-3F77C7816C40Q52582495-89B74997-C0A1-4B11-96C3-603922B44F3DQ52604643-A916BF00-67CF-4339-95B4-0D0DD57AE30BQ55279818-12044B2E-D3BD-452E-ABDE-842A7CA19BE3Q57171226-CB9CD879-97BC-48AA-A579-4B15DB31F32EQ57810275-7A8D9EA9-6FA6-49C0-AB2B-BACF515ABC5AQ58705993-D3EBE157-22DF-4303-A9B9-A71E76923E57
P2860
Evaluation, in three provinces, of the introduction and impact of China's National Essential Medicines Scheme
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Evaluation, in three provinces ...... nal Essential Medicines Scheme
@ast
Evaluation, in three provinces ...... nal Essential Medicines Scheme
@en
type
label
Evaluation, in three provinces ...... nal Essential Medicines Scheme
@ast
Evaluation, in three provinces ...... nal Essential Medicines Scheme
@en
prefLabel
Evaluation, in three provinces ...... nal Essential Medicines Scheme
@ast
Evaluation, in three provinces ...... nal Essential Medicines Scheme
@en
P2093
P2860
P356
P1476
Evaluation, in three provinces ...... nal Essential Medicines Scheme
@en
P2093
David Hipgrave
Guo Sufang
Philippa Brant
P2860
P304
P356
10.2471/BLT.11.097998
P407
P577
2013-01-11T00:00:00Z